SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-019166
Filing Date
2023-05-09
Accepted
2023-05-09 08:21:29
Documents
52
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cogt-20230331.htm   iXBRL 10-Q 1606419
2 EX-31.1 cogt-ex31_1.htm EX-31 16905
3 EX-31.2 cogt-ex31_2.htm EX-31 16893
4 EX-32.1 cogt-ex32_1.htm EX-32 11323
5 EX-32.2 cogt-ex32_2.htm EX-32 11298
6 GRAPHIC img157441556_0.jpg GRAPHIC 39318
  Complete submission text file 0000950170-23-019166.txt   5691457

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cogt-20230331_def.xml EX-101.DEF 138005
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cogt-20230331_pre.xml EX-101.PRE 222420
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cogt-20230331_cal.xml EX-101.CAL 35522
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cogt-20230331_lab.xml EX-101.LAB 303340
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cogt-20230331.xsd EX-101.SCH 34340
46 EXTRACTED XBRL INSTANCE DOCUMENT cogt-20230331_htm.xml XML 907645
Mailing Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451
Business Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451 617-945-5576
Cogent Biosciences, Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38443 | Film No.: 23900102
SIC: 2834 Pharmaceutical Preparations